Optimizing Heme Oxygenase Activity after CNS Hemorrhage
Optimizing Heme Oxygenase Activity after CNS Hemorrhage
批准号:
7340719
负责人:
RAYMOND F REGAN
金额:
$23.7万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2009-12-31
关键词:
ALPPAccountingAdenovirus VectorAdenovirusesAffectAstrocytesAttenuatedAutologousBloodBlood ClotBlood coagulationBrain InjuriesBrain hemorrhageCell DeathCell SurvivalCerebral hemisphere hemorrhageChelating AgentsCoagulation ProcessCorpus striatum structureCraniocerebral TraumaCytolysisDevelopmentDiseaseDrug Delivery SystemsEdemaEnzyme GeneEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesErythrocytesGF109203XGene DeletionGene TransferGenesGenetic TranscriptionGlial Fibrillary Acidic ProteinGoalsHematomaHemeHeminHemoglobinHemorrhageHourHumanImmunoblottingImmunohistochemistryInjection of therapeutic agentInjuryIronIschemiaIschemic StrokeLaboratoriesLate EffectsLeadLesionLifeLipid PeroxidationLipidsMediatingMorbidity - disease rateMusNeurogliaNeurologicNeuronsOxidative StressOxygenasesPathway interactionsPhosphorylationPhosphotransferasesPrevalenceProcessProtein IsoformsProtein Kinase C InhibitorProteinsReactive Oxygen SpeciesRecombinantsRegulationResearch PersonnelResistanceSiteStaining methodStainsStrokeSubarachnoid HemorrhageSurvivorsSynapsinsTherapeutic InterventionThrombinTimeTissuesToxic effectTraumaTraumatic CNS injuryVirus Diseasesbenzotriazolecell typedesignenzyme activitygene therapyheme oxygenase-1heme oxygenase-2improvedinhibitor/antagonistinjuredintraperitonealmortalityneurotoxicityoxidationpreventprogramspromotertherapeutic targettreatment effectvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Intracerebral hemorrhage accompanies most CNS traumatic injuries and about 15% of strokes. Increasing
9vidence suggests that hemoglobin (Hb) release from lysing erythrocytes may contribute to oxidative stress
n surrounding tissue. Because of its prolonged time course, Hb toxicity may be an ideal target for
therapeutic intervention. Prior studies have demonstrated that Hb affects the survival of neurons and
astrocytes by pathways that are largely dependent on the heme oxygenase enzymes (HO). HO-1 is
inducible, and is found primarily in glia, where it is protective; HO-2 is expressed mainly in neurons, where it
worsens injury. Unfortunately, HO inhibitors block both isoforms, and increase injury to astrocytes while
protecting neurons. The goal of this project is to develop a strategy that will optimize HO activity in both cell
types after hemorrhage. We hypothesize that this may be accomplished by two approaches: 1) exploiting
differences in the regulation of HO-1 and HO-2 activation; 2) transferring sense and antisense HO genes
with promoters that target transcription to specific cell types. Our experimental aims are as follows: 1)
Decrease neuronal HO-2 activity in cortical cultures by inhibiting its activation by CK2, using specific
benzotriazole inhibitors. Determine the effect of this treatment on culture HO activity, reactive oxygen
species (ROS) formation, and cell viability after Hb or hemin exposure. 2) Construct an adenovirus encoding
the HO-1 gene driven by the astrocyte-specific GFAP promoter. Quantify its expression in astrocytes and
neurons, and determine its effect on heme-mediated ROS formation and cell death. 3) Construct an
adenovirus containing the HO-2 gene in antisense orientation, driven by the neuron-specific synapsin-1
promoter. Quantify its effect on HO-2 expression in cultured astrocytes and neurons, and on heme-mediated
oxidative injury. 4) Stereotactically inject blood into the striata of mice, alone or with sense HO-1, antisense
HO-2, or both vectors. Alternatively, treat blood-injected mice with intraperitoneal CK2 inhibitors. At 72 and
144 hours, determine the effect on lesion volume using TTC staining. Quantify cellular protein and lipid
oxidation in surrounding tissue. The information gained in this project may lead to new treatments for victims
of hemorrhagic stroke and head trauma. The ultimate goal is to reduce brain injury in tissue surrounding a
blood clot, and to thereby improve the likelihood of survival and return to an independent, productive life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protective effect of astrocyte heme oxygenase-1 after intracerebral hemorrhage
-
批准号:9914357
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2018
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Hemopexin Therapy after Intracerebral Hemorrhage
-
批准号:8969426
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2015
-
负责人:RAYMOND F REGAN
-
依托单位:
Protective Effect of Hemin Preconditioning after Intracerebral Hemorrhage
-
批准号:8847812
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2012
-
负责人:RAYMOND F REGAN
-
依托单位:
Protective Effect of Hemin Preconditioning after Intracerebral Hemorrhage
-
批准号:8346310
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2012
-
负责人:RAYMOND F REGAN
-
依托单位:
Protective Effect of Hemin Preconditioning after Intracerebral Hemorrhage
-
批准号:8472555
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2012
-
负责人:RAYMOND F REGAN
-
依托单位:
Protective Effect of Hemin Preconditioning after Intracerebral Hemorrhage
-
批准号:8661320
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2012
-
负责人:RAYMOND F REGAN
-
依托单位:
A fluorescent method to quantify neuronal injury after intracerebral hemorrhage
-
批准号:8191650
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2011
-
负责人:RAYMOND F REGAN
-
依托单位:
A fluorescent method to quantify neuronal injury after intracerebral hemorrhage
-
批准号:8290451
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2011
-
负责人:RAYMOND F REGAN
-
依托单位:
Optimizing Heme Oxygenase Activity after CNS Hemorrhage
-
批准号:7046350
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2006
-
负责人:RAYMOND F REGAN
-
依托单位:
Optimizing Heme Oxygenase Activity after CNS Hemorrhage
-
批准号:7162512
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2006
-
负责人:RAYMOND F REGAN
-
依托单位:
Optimizing Heme Oxygenase Activity after CNS Hemorrhage
-
批准号:7545509
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2006
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:7616228
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:7426885
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:7830896
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:6474840
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:6821363
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:6982764
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:6685926
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:7846098
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2002
-
负责人:RAYMOND F REGAN
-
依托单位:
Effect of Inducible Antioxidants on Hemoglobin Toxicity
-
批准号:7317207
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2001
-
负责人:RAYMOND F REGAN
-
依托单位:
海外基金